SCHEMBL1098142

SCHEMBL1098142

COC(=O)c1ccc(CN(c2sc3ccccc3c2Br)S(=O)(=O)c2cccnc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.51
ALDH1A1 P00352 1/20 0.51
TRPM8 Q7Z2W7 5/20 0.47
LMNA P02545 1/20 0.42
HTT P42858 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
MMP9 P14780 4/20 0.42
MMP13 P45452 4/20 0.42
MMP1 P03956 3/20 0.42
ADAM17 P78536 3/20 0.42
PSEN1 P49768 1/20 0.40
PSEN2 P49810 1/20 0.40
APH1B Q8WW43 1/20 0.40
NCSTN Q92542 1/20 0.40
APH1A Q96BI3 1/20 0.40
PSENEN Q9NZ42 1/20 0.40
RAB9A P51151 4/20 0.40
NPC1 O15118 2/20 0.40
KMT2A Q03164 1/20 0.40
GAA P10253 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1099423 0.91 MMP9 (0.44) KDM4EALDH1A1TRPM8LMNAHTT
SCHEMBL1098734 0.83 TRPM8 (0.56) TRPM8
SCHEMBL1099310 0.80 KDM4E (0.52) KDM4EALDH1A1TRPM8LMNAHTT
SCHEMBL18422594 0.80 ALDH1A1 (0.64) KDM4EALDH1A1LMNAHTTNPSR1
SCHEMBL1098774 0.80 KMT2A (0.44) ALDH1A1LMNAHTTNPSR1MMP9
SCHEMBL1098446 0.80 TRPM8 (0.44) TRPM8LMNAHTTNPSR1KMT2A
SCHEMBL1098170 0.77 TRPM8 (0.69) KDM4EALDH1A1TRPM8MMP9MMP13
SCHEMBL1098279 0.77 PKM (0.49) KDM4EALDH1A1TRPM8LMNANPC1
SCHEMBL1097497 0.77 TRPM8 (0.57) TRPM8MMP9MMP13MMP1ADAM17
SCHEMBL1100218 0.77 TRPM8 (0.57) TRPM8LMNAHTTNPSR1MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9434711-B2 Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, N.V. (BE) 2016-09-06 US disclosed
US-20140315899-A1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2014-10-23 US disclosed
US-8809327-B2 Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, NV (BE) 2014-08-19 US disclosed
EP-2183239-B1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2012-08-22 EP disclosed
US-20120190674-A1 SULFONAMIDES AS TRPM8 MODULATORS BRANUM SHAWN T (US) 2012-07-26 US disclosed
US-8153682-B2 Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, NV (BE) 2012-04-10 US disclosed
US-20090264474-A1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA, N.V. (BE) 2009-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120190674-A1 SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPM5, TRPM2 KDM4E 3266/4885ALDH1A1 3091/4885TRPM8 1/4885
US-20140315899-A1 SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPM5, TRPM2 KDM4E 3266/4885ALDH1A1 3091/4885TRPM8 1/4885
US-20090264474-A1 SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPM5, TRPM2 KDM4E 3266/4885ALDH1A1 3091/4885TRPM8 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.